Stock comparison
BOSTON SCIENTIFIC CORP is 1.4x more valuable than Medline Inc. by market capitalization ($66.87 B vs $49.12 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
BSX is larger
BOSTON SCIENTIFIC CORP is 1.4x more valuable than Medline Inc. by market capitalization ($66.87 B vs $49.12 B).
Market value leader
BSX
BOSTON SCIENTIFIC CORP is 1.4x more valuable than Medline Inc. by market capitalization ($66.87 B vs $49.12 B).
Revenue leader
MDLN
BSX: $20.07B vs MDLN: $28.43B.
| Metric | BSX | MDLN |
|---|---|---|
| Market cap | $66.87 B | $49.12 B |
| US-listed rank | #256 | #328 |
| Revenue (latest FY) | $20.07B | $28.43B |
| Net income (latest FY) | - | $1.16T |
| Net margin | - | 4069.4% |
| P/E (trailing FY) | - | 0.0x |
| SEC filings | 1,009 | 103 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
BOSTON SCIENTIFIC CORP is 1.4x more valuable than Medline Inc. by market capitalization ($66.87 B vs $49.12 B).
In their latest fiscal years, BOSTON SCIENTIFIC CORP reported $20.07B in revenue while Medline Inc. reported $28.43B.
Full pages: BOSTON SCIENTIFIC CORP and Medline Inc., or browse the full rankings.